Short-term intensive combined therapy with metformin, sagliptin and dapagliflozin for newly diagnosed type 2 diabetes:efficacy, weight control and safety

XU Yufeng; WU Peili; WEN Weiheng; CHEN Hong

doi:10.12122/j.issn.1673-4254.2019.11.07

Home>Articles>Short-term intensive combined therapy with metformin, sagliptin and dapagliflozin for newly diagnosed type 2 diabetes:efficacy, weight control and safety

DOI: 10.12122/j.issn.1673-4254.2019.11.07

Short-term intensive combined therapy with metformin, sagliptin and dapagliflozin for newly diagnosed type 2 diabetes:efficacy, weight control and safety

XU Yufeng

WU Peili

WEN Weiheng

CHEN Hong

Machine-generated Keywords：

Publication Date：2019-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：7( 1305-1311 )

Journal of Southern Medical University

PKUISTIC

ISSN：1673-4254

Year, Vol.(Issue)：2019,39(11)